Partnership Forum: This forum identified key actions that can support access to and the appropriate management of treatments for rare diseases within the U.S. health care system.
During AMCP Legislative Day 2020, 40 AMCP members met with lawmakers in targeted congressional offices on AMCP’s key issues to explain the value of managed care pharmacy in the broader health care system.
Sponsored webinar that provided an overview of the ATTR amyloidosis disease subtypes, pathophysiology of disease, and the varying clinical presentations, including nonspecific symptoms that should raise suspicion of and aid in diagnosis of the disease.
More than 30 experts representing health plans, integrated delivery systems, health economists, providers, academicians, pharmaceutical manufacturers, and other professionals gathered for AMCP’s Partnership Forum to address the challenges in managing and providing timely access to rare and orphan disease therapies.